SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lana X. Tong, Scott D. Worswick, Viral infections in acute graft-versus-host disease: A review of diagnostic and therapeutic approaches, Journal of the American Academy of Dermatology, 2015, 72, 4, 696

    CrossRef

  2. 2
    M. Mikulska, L. Nicolini, A. Signori, G. Rivoli, V. Del Bono, A. M. Raiola, C. Di Grazia, A. Dominietto, R. Varaldo, A. Ghiso, A. Bacigalupo, C. Viscoli, Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome, Clinical Microbiology and Infection, 2014, 20, 10
  3. 3
    M. Takahata, S. Hashino, M. Onozawa, A. Shigematsu, J. Sugita, K. Fujimoto, T. Endo, T. Kondo, J. Tanaka, M. Imamura, T. Teshima, Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection, Transplant Infectious Disease, 2014, 16, 5
  4. 4
    Akihiro Tamori, Masayuki Hino, Etsushi Kawamura, Hideki Fujii, Sawako Uchida-Kobayashi, Hiroyasu Morikawa, Hirohisa Nakamae, Masaru Enomoto, Yoshiki Murakami, Norifumi Kawada, Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy, Journal of Gastroenterology and Hepatology, 2014, 29, 9
  5. 5
    Merih Kızıl Çakar, Elif Suyanı, Gülsan Türköz Sucak, Şermin Altındal, Şahika Zeynep Akı, Kadir Acar, Münci Yağcı, Seyyal Rota, Seren Özenirler, HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey, Annals of Hematology, 2013, 92, 3, 395

    CrossRef

  6. 6
    B.W. Teh, M.A. Slavin, J. Szer, J.J. Sasadeusz, Hepatitis B serological changes following allogeneic bone marrow transplantation, Transplant Infectious Disease, 2013, 15, 1
  7. 7
    Axel Schubert, Detlef Michel, Thomas Mertens, Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation, BMC Infectious Diseases, 2013, 13, 1, 223

    CrossRef

  8. 8
    Ferruccio Bonino, Maurizia Rossana Brunetto, Occult Hepatitis B Virus (HBV) Infections: Hepatitis B Surface Antigen (HBsAg) Negative and Primary Occult, Current Hepatitis Reports, 2013, 12, 2, 112

    CrossRef

  9. 9
    M. Tomblyn, M. Chen, M. Kukreja, M.D. Aljurf, F. Al Mohareb, B.J. Bolwell, J.-Y. Cahn, M.H. Carabasi, R.P. Gale, R.E. Gress, V. Gupta, G.A. Hale, P. Ljungman, R.T. Maziarz, J. Storek, J.R. Wingard, J.-A.H. Young, M.M. Horowitz, K.K. Ballen, No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation, Transplant Infectious Disease, 2012, 14, 5
  10. 10
    Panagiotis Papamichalis, Alexis Alexiou, Maria Boulbou, George N. Dalekos, Eirini I. Rigopoulou, Reactivation of resolved hepatitis B virus infection after immunosuppression: Is it time to adopt pre-emptive therapy?, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 1, 84

    CrossRef

  11. 11
    Silvia Park, Kihyun Kim, Dong Hwan Kim, Jun Ho Jang, Seok Jin Kim, Won Seog Kim, Chul Won Jung, Kwang Cheol Koh, Changes of Hepatitis B Virus Serologic Status after Allogeneic Hematopoietic Stem Cell Transplantation and Impact of Donor Immunity on Hepatitis B Virus, Biology of Blood and Marrow Transplantation, 2011, 17, 11, 1630

    CrossRef

  12. 12
    H.-R. Li, J.-J. Huang, H.-Q. Guo, X. Zhang, Y. Xie, H.-L. Zhu, L.-Z. Zhai, X.-X. Pu, Y. Huang, C.-C. Guo, T.-Y. Lin, Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy, Journal of Viral Hepatitis, 2011, 18, 12
  13. 13
    M Viganò, C Vener, P Lampertico, C Annaloro, C Pichoud, F Zoulim, F Facchetti, F Poli, M Scalamogna, G Lambertenghi Deliliers, M Colombo, Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT, Bone Marrow Transplantation, 2011, 46, 1, 125

    CrossRef

  14. 14
    Inken Hilgendorf, Mathias Freund, Wolfgang Jilg, Hermann Einsele, Juan Gea-Banacloche, Hildegard Greinix, Jörg Halter, Anita Lawitschka, Daniel Wolff, Roland Meisel, Vaccination of allogeneic haematopoietic stem cell transplant recipients: Report from the International Consensus Conference on Clinical Practice in chronic GVHD, Vaccine, 2011, 29, 16, 2825

    CrossRef

  15. 15
    Resat Ozaras, Cem Ar, Seniz Ongoren, Bilgul Mete, Fehmi Tabak, Ali Mert, Recep Ozturk, Acute hepatitis B despite a previous high titer of anti-HBs, Hepatology International, 2010, 4, 2, 530

    CrossRef

  16. 16
    Kavitha Gopal, Albert D. Min, Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant, Current Hepatitis Reports, 2010, 9, 3, 178

    CrossRef

  17. 17
    P. Borentain, P. Colson, D. Coso, E. Bories, A. Charbonnier, A. M. Stoppa, T. Auran, A. Loundou, A. Motte, E. Ressiot, E. Norguet, C. Chabannon, R. Bouabdallah, C. Tamalet, R. Gérolami, Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer, Journal of Viral Hepatitis, 2010, 17, 11
  18. You have free access to this content18
    John S Lubel, Peter W Angus, Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management, Journal of Gastroenterology and Hepatology, 2010, 25, 5
  19. 19
    Carlos A. Ramos, Rima M. Saliba, Leandro de Pádua Silva, Ola Khorshid, Elizabeth J. Shpall, Sergio Giralt, Poliana A. Patah, Chitra M. Hosing, Uday R. Popat, Gabriela Rondon, Yago Nieto, Richard E. Champlin, Marcos de Lima, Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2010, 16, 5, 686

    CrossRef

  20. 20
    Sarah P. Hammond, Anne Marie Borchelt, Chinweike Ukomadu, Vincent T. Ho, Lindsey R. Baden, Francisco M. Marty, Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2009, 15, 9, 1049

    CrossRef

  21. 21
    Kosei Matsue, Takatoshi Aoki, Jun Odawara, Hideaki Fujiwara, Kan-ichi Iwama, Shun-ichi Kimura, Masayuki Yamakura, Masami Takeuch, High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients, European Journal of Haematology, 2009, 83, 4
  22. 22
    R. Liang, How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation, Blood, 2009, 113, 14, 3147

    CrossRef

  23. 23
    Quan Le, Aarthi Shenoy, Eleftheria Koklanaris, Richard Childs, A. John Barrett, Bipin N. Savani, Lamivudine Prophylaxis and Hepatitis B Vaccination for Prevention of Hepatitis B Virus Reverse Seroconversion in Long-Term Survivors after Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2009, 15, 7, 886

    CrossRef

  24. 24
    Daniel Candotti, Jean-Pierre Allain, Transfusion-transmitted hepatitis B virus infection, Journal of Hepatology, 2009, 51, 4, 798

    CrossRef

  25. 25
    Masahiro Onozawa, Satoshi Hashino, Stephanie Darmanin, Kohei Okada, Rena Morita, Mutsumi Takahata, Akio Shigematsu, Kaoru Kahata, Takeshi Kondo, Junji Tanaka, Masahiro Imamura, Masahiro Asaka, HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV Infection, Biology of Blood and Marrow Transplantation, 2008, 14, 11, 1226

    CrossRef

  26. 26
    Jo-Anne H. Young, Infectious complications of acute and chronic GVHD, Best Practice & Research Clinical Haematology, 2008, 21, 2, 343

    CrossRef

  27. 27
    Tomasz I Michalak, Tram NQ Pham, Patricia M Mulrooney-Cousins, Molecular diagnosis of occult HCV and HBV infections, Future Virology, 2007, 2, 5, 451

    CrossRef